{
    "Trade/Device Name(s)": [
        "VeriClear Digital Early Result Pregnancy Test",
        "VeriClearTM Digital Early Result Pregnancy Test"
    ],
    "Submitter Information": "True Diagnostics, Inc.",
    "510(k) Number": "K182328",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123567"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "May 15, 2019",
    "Summary Letter Received Date": "April 5, 2019",
    "Submission Date": "May 13, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)",
        "Intact hCG",
        "Hyperglycosylated hCG",
        "hCG \u03b2-subunit"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "VeriClear Digital Early Result Pregnancy Test (integrated device with digital reader)"
    ],
    "Method(s)/Technology(ies)": [
        "Chromatographic immunoassay",
        "Lateral flow",
        "Digital result display"
    ],
    "Methodologies": [
        "Immunochromatographic assay"
    ],
    "Submission Type(s)": [
        "Test",
        "Device",
        "Reader"
    ],
    "Document Summary": "FDA 510(k) summary for VeriClear Digital Early Result Pregnancy Test, a qualitative chromatographic immunoassay for detection of hCG in urine with digital readout.",
    "Indications for Use Summary": "Rapid chromatographic immunoassay for qualitative detection of hCG in urine as an aid in early detection of pregnancy, in some cases as early as five days before the expected period; intended for over-the-counter use.",
    "fda_folder": "Clinical Chemistry"
}